Security key
218352102
CORCEPT THERAPEUTICS INC - COMMON STOCK (CORT)
CUSIP: 218352102
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 93,600,393
- Total 13F value
- $2,357,405,516
- Share change
- +8,680,155
- Put/Call ratio
- 162%
- SEC-reported price per share
- $25.19
- Number of holders
- 283
- Value change
- +$206,853,940
- Number of buys
- 157
- Number of sells
- 127
- Shares outstanding
- 106,815,676
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2024
Institutions
283
Top holders
10
CORT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
CORCEPT THERAPEUTICS INC SEC filings
CORCEPT THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 218352102
Recent filing periods:
Ownership snapshot
Top reported holders of CORT - CORCEPT THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock Finance, Inc.
15%
VANGUARD GROUP INC
8.9%
INGALLS & SNYDER LLC
7.8%
RENAISSANCE TECHNOLOGIES LLC
6.3%
Parallel Advisors, LLC
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
Company
|
15%
|
$532,921,965
16,407,696 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
8.9%
|
$309,779,039
9,537,532 shares
|
— | 31 Dec 2023 |
| INGALLS & SNYDER LLC |
13F
Company
|
7.8%
|
$271,267,000
8,351,827 shares
|
— | 31 Dec 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
6.3%
|
$218,456,000
6,725,871 shares
|
— | 31 Dec 2023 |
| Parallel Advisors, LLC |
13F
Company
|
3.5%
|
$122,392,598
3,768,245 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
3.2%
|
$110,024,863
3,387,465 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
283
Shares
93,600,393
Rows available
283
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
269
Q1 2024 holders
283
Holder diff
14
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend